Delivery Order SPE2DR25D3301-SPE2DR26F18TZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at approximately $13,969 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,587.15 for Vemlidy 25 mg tablets (30-count units) with a firm fixed price structure. This non-set-aside delivery order was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing the...
- The Defense Logistics Agency awarded a delivery order valued at $2,919.85 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, reflecting...
- The Defense Logistics Agency awarded a $15,016.53 delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Vemlidy 25 mg on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in hepatitis B treatment, reflecting the Defense Logistics Agency's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,475.87 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price delivery order was executed on November 18, 2025, with an ultimate completion date of November 19, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,656.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units). This contract was competitively awarded with firm fixed pricing and no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of May 14, 2025. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B,...
- The Defense Logistics Agency awarded a delivery order valued at $20,721.48 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on October 28, 2025, with completion scheduled for October 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,079.30 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic...
- The Defense Logistics Agency awarded a delivery order valued at $8,204.95 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on December 2, 2025, with completion expected by December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. Vemlidy is a prescription antiviral medication used in hepatitis B treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a $3,914.81 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in hepatitis B treatment, representing part of the Defense...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18TZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) valued at $20,196.06 under a firm fixed-price contract. This non-set-aside award was issued on December 1, 2025, with an ultimate completion date of December 2, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Vemlidy is an antiviral medication used in hepatitis B treatment, consistent with AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Through its substantial federal contract portfolio with DLA, AmerisourceBergen demonstrates extensive capability in fulfilling competitive federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.2k | 11/30/25 |